您当前所在的位置:首页 > 产品中心 > 产品信息
Tolvaptan_分子结构_CAS_150683-30-0)
点击图片或这里关闭

Tolvaptan

产品号 Bio-0936 公司名称 InterBioScreen
CAS号 150683-30-0 公司网站 http://www.ibscreen.com
分子式 C26H25ClN2O3 电 话 +7 49652 40091
分子量 448.9413 传 真 +7 49652 40092
纯 度 电子邮件 screen@ibscreen.chg.ru
保 存 Chembase数据库ID: 178726

产品价格信息

请登录

产品别名

标题
Tolvaptan
IUPAC标准名
N-{4-[(5R)-7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carbonyl]-3-methylphenyl}-2-methylbenzamide
IUPAC传统名
N-{4-[(5R)-7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carbonyl]-3-methylphenyl}-2-methylbenzamide
别名
Samsca
OPC-41061

产品登记号

CAS号 150683-30-0

产品性质

生物活性机理 Vasopressin V2 receptor antagonist
应用领域 Used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH).

产品详细信息

参考文献

  • 2. Shoaf S, Elizari M, Wang Z et al. (2005). "Tolvaptan administration does not affect steady state amiodarone concentrations in patients with cardiac arrhythmias". J Cardiovasc Pharmacol Ther 10 (3):
  • 165?1.
  • 3. Gheorghiade M, Gattis W, O'Connor C et al. (2004). "Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial". JAMA 291 (
  • 16): 1963?1.
  • 1. Gheorghiade M, Niazi I, Ouyang J et al. (2003). "Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial". Circulation
  • 107 (21): 2690?